Ellomay Capital Ltd. (NYSEAMERICAN:ELLO – Get Free Report) saw a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 343 shares, a drop of 39.7% from the May 14th total of 569 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 16,027 shares, the short-interest ratio is currently 0.0 days.
Ellomay Capital Trading Up 2.1%
Shares of NYSEAMERICAN ELLO traded up $0.45 during midday trading on Monday, hitting $21.56. The stock had a trading volume of 16,968 shares, compared to its average volume of 9,264. The company’s 50-day simple moving average is $23.87 and its 200 day simple moving average is $24.70. The firm has a market cap of $297.10 million, a P/E ratio of -12.53 and a beta of 0.94. Ellomay Capital has a fifty-two week low of $13.71 and a fifty-two week high of $30.34. The company has a debt-to-equity ratio of 3.62, a current ratio of 1.40 and a quick ratio of 1.40.
Ellomay Capital (NYSEAMERICAN:ELLO – Get Free Report) last released its earnings results on Saturday, May 16th. The utilities provider reported ($0.88) EPS for the quarter. The firm had revenue of $10.03 million during the quarter. Ellomay Capital had a negative net margin of 45.04% and a negative return on equity of 12.39%.
Institutional Investors Weigh In On Ellomay Capital
Ellomay Capital Company Profile
Ellomay Capital Ltd. is an Israel-based investment company specializing in the acquisition, financing, development and operation of renewable energy and related infrastructure assets. Founded in 2014 and traded on the NYSE American under the ticker ELLO, Ellomay focuses on building a diversified portfolio of solar photovoltaic (PV) projects and specialty infrastructure businesses that generate stable, long-term cash flows under government-backed tariffs and concession agreements.
The company’s core activities center on ground-mounted solar PV installations in Italy, where its operating portfolio comprises multiple medium-sized projects secured under feed-in-tariff regimes.
Featured Stories
- Five stocks we like better than Ellomay Capital
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Ellomay Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellomay Capital and related companies with MarketBeat.com's FREE daily email newsletter.
